I. Product Parameters:Model: P-PCF60 、P-PCF60/L(Pre-loaded)Power: 0-30.0D(increasement 0.5D)Diameter of main body: 6.0mmTotal diameter: 125mm、12.75mmHaptic angle: 5°A constant:118.4Incision size of pre-loaded injection system: 2.2mm
1.Theintraoculabiocompatibilityand excelhomogeneltZero-impuritytechnology is adopted for the material polymerization. The nanometer numerical control processingtechnology and proprietary hydration cleaning technology are adopted for production and processing.With high product purity and no glistening, there is no product turbidity and impurity deposition causedbv the material after the operation.
2.With modified C-shaped haptic design, the capsular bag has a large supporting contact angle, whichcan suit different size capsular bags and provides guarantee for maintaining the product centering afterthe operation. It has the sharp angle square edge design, so the product closely adheres to the posteriorcapsule to form a protective barrier, thereby preventing epithelial cells from migrating to the posteriorcapsule andreducing theincidence ofPCO.
3.Due to the design ofhigh-order zero spherical aberration aspheric surface intraocular lens, there isno spherical aberration, precise focusing, and good contrast sensitivity, so that the vision is clearer.
4.The total diameters ofthe products are l2.5mm and 12.75mm, which can meet the needs of capsularbags of different sizes implanting intraocularlenses, avoiding tilting, eccentricity and rotation of theproduct due to slack capsular bags , and improving postoperative visual quality.
5.The intraocular lens is pre-loaded in the holder at the factory in standardization, so as to reduce theprocess ofloading lenses during the operation compared with the traditional method. improve thestandardization operation level, avoid the failure ofinjection, and reduce the operation time. During theoperation, medical staffs do not need to touch the intraocular lens, which reduces the chance of processcontamination and reduces the incidence ofintraocular inflammation.
6.The design ofthe pre-loaded injection system meets the ergonomic requirements, with goodcontrollability and more convenient operation, and meets 2.2 mm micro incision surgery, with smallsurgical astigmatism,quick recovery of postoperative vision, and improved postoperative visual quality.
I. Product Parameters:Model: P-PCF60 、P-PCF60/L(Pre-loaded)Power: 0-30.0D(increasement 0.5D)Diameter of main body: 6.0mmTotal diameter: 125mm、12.75mmHaptic angle: 5°A constant:118.4Incision size of pre-loaded injection system: 2.2mm
1.Theintraoculabiocompatibilityand excelhomogeneltZero-impuritytechnology is adopted for the material polymerization. The nanometer numerical control processingtechnology and proprietary hydration cleaning technology are adopted for production and processing.With high product purity and no glistening, there is no product turbidity and impurity deposition causedbv the material after the operation.
2.With modified C-shaped haptic design, the capsular bag has a large supporting contact angle, whichcan suit different size capsular bags and provides guarantee for maintaining the product centering afterthe operation. It has the sharp angle square edge design, so the product closely adheres to the posteriorcapsule to form a protective barrier, thereby preventing epithelial cells from migrating to the posteriorcapsule andreducing theincidence ofPCO.
3.Due to the design ofhigh-order zero spherical aberration aspheric surface intraocular lens, there isno spherical aberration, precise focusing, and good contrast sensitivity, so that the vision is clearer.
4.The total diameters ofthe products are l2.5mm and 12.75mm, which can meet the needs of capsularbags of different sizes implanting intraocularlenses, avoiding tilting, eccentricity and rotation of theproduct due to slack capsular bags , and improving postoperative visual quality.
5.The intraocular lens is pre-loaded in the holder at the factory in standardization, so as to reduce theprocess ofloading lenses during the operation compared with the traditional method. improve thestandardization operation level, avoid the failure ofinjection, and reduce the operation time. During theoperation, medical staffs do not need to touch the intraocular lens, which reduces the chance of processcontamination and reduces the incidence ofintraocular inflammation.
6.The design ofthe pre-loaded injection system meets the ergonomic requirements, with goodcontrollability and more convenient operation, and meets 2.2 mm micro incision surgery, with smallsurgical astigmatism,quick recovery of postoperative vision, and improved postoperative visual quality.
